Ruxotop 1,5% Topical cream 60 g

Ruxotop 1,5% Topical cream 60 g

Composition:

Active ingredient:
Ruxolitinib 15 mg/g (1.5%).

Product Description: 

Ruxotop is a topical formulation of ruxolitinib, a Janus kinase (JAK) inhibitor.
It is designed for dermatological use to reduce inflammation and immune-mediated skin reactions.

Indications for use:

Atopic dermatitis (eczema).
Vitiligo (depigmentation disorders).
Other inflammatory dermatoses as directed by a physician.

Method of administration and dosage:

Apply a thin layer to affected skin areas twice daily, or as prescribed.
For external use only.
Duration of treatment depends on clinical response and physician guidance.

Contraindications:

Hypersensitivity to ruxolitinib or excipients.
Not for ophthalmic, oral, or intravaginal use.

Precautions:

Use only under medical supervision.
Avoid application to broken or infected skin unless directed.
Monitor for systemic absorption in long-term or extensive use.

Side effects:

Possible local reactions: redness, burning, itching.
Rare systemic effects: immunosuppression, increased infection risk.

Pregnancy and lactation: 

Use only if potential benefit outweighs risk;
consult physician.

Storage conditions: 

Store below 25°C in a dry place.
Keep out of reach of children.

Packaging: 

Tube 60 g topical cream, in carton box.